{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:37:02Z","timestamp":1760524622239,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by hypophosphatemia, bone mineralization disorders with increased risk of fragility fractures, muscle pain, and progressive weakness. TIO has been associated with increased production of the phosphaturic hormone Fibroblast Growth Factor 23 (FGF23) usually by mesenchymal tumors of soft tissue or bone (Phosphaturic Mesenchymal Tumors\u2014PMTs). In rare cases TIO may be observed in association with other malignancies. We report the case of a 66-year-old woman with an occasional diagnosis of both a PMT and an ovarian cancer during the evaluation of TIO. We also systematically review the literature to discover possible correlations between osteomalacia, FGF23 production, and ovarian cancer. Four studies were eligible for the analysis. Two case reports described an association between TIO development and ovarian cancer, whereas the two case-control studies hypothesized a possible correlation between FGF\/FGF receptor axis and cancer development. Although it does not provide conclusive evidence regarding the association between TIO and ovarian cancer, this case report highlights the possibility that in the diagnostic workup of suspected TIO, both FGF23-secreting tumors distinct from PMT and tumors unrelated to the clinical presentation of TIO could be identified. This information is important for guiding successful tumor staging and determining the necessity for surgical intervention and\/or eventual adjuvant therapy.<\/jats:p>","DOI":"10.1007\/s00223-024-01231-2","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T22:01:43Z","timestamp":1716933703000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review"],"prefix":"10.1007","volume":"115","author":[{"given":"Marcodomenico","family":"Mazza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-4449","authenticated-orcid":false,"given":"Gaetano Paride","family":"Arcidiacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilda","family":"Hoxhaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Burei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Sella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/endrev\/bnac026","volume":"44","author":"S Minisola","year":"2023","unstructured":"Minisola S, Fukumoto S, Xia W et al (2023) Tumor-induced osteomalacia: a comprehensive review. Endocr Rev 44:323\u2013353. https:\/\/doi.org\/10.1210\/endrev\/bnac026","journal-title":"Endocr Rev"},{"key":"1231_CR2","first-page":"33","volume":"16","author":"RA McCance","year":"1947","unstructured":"McCance RA (1947) Osteomalacia with looser\u2019s nodes (milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med 16:33\u201346","journal-title":"Q J Med"},{"key":"1231_CR3","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader A, Illig R, Uehlinger E, Stalder G (1959) Rickets following bone tumor. Helv Paediatr Acta 14:554\u2013565","journal-title":"Helv Paediatr Acta"},{"key":"1231_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"Boland JM, Tebben PJ, Folpe AL (2018) Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Invest 41:1173\u20131184. https:\/\/doi.org\/10.1007\/s40618-018-0849-5","journal-title":"J Endocrinol Invest"},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1297\/cpe.29.69","volume":"29","author":"N Oyama","year":"2020","unstructured":"Oyama N, Kojima-Ishii K, Toda N et al (2020) Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review. Clin Pediatr Endocrinol Case Rep Clin Investig Off J Jpn Soc Pediatr Endocrinol 29:69\u201375. https:\/\/doi.org\/10.1297\/cpe.29.69","journal-title":"Clin Pediatr Endocrinol Case Rep Clin Investig Off J Jpn Soc Pediatr Endocrinol"},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD et al (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity. Am J Surg Pathol 28:1\u201330. https:\/\/doi.org\/10.1097\/00000478-200401000-00001","journal-title":"Am J Surg Pathol"},{"key":"1231_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7326\/0003-4819-93-2-275","volume":"93","author":"KW Lyles","year":"1980","unstructured":"Lyles KW, Berry WR, Haussler M et al (1980) Hypophosphatemic osteomalacia: association with prostatic carcinoma. Ann Intern Med 93:275\u2013278. https:\/\/doi.org\/10.7326\/0003-4819-93-2-275","journal-title":"Ann Intern Med"},{"key":"1231_CR8","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00520-012-1474-z","volume":"20","author":"MP Mak","year":"2012","unstructured":"Mak MP, da Costa e Silva VT, Martin RM et al (2012) Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 20:2195\u20132197. https:\/\/doi.org\/10.1007\/s00520-012-1474-z","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"1231_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40200-019-00398-y","volume":"18","author":"C Savva","year":"2019","unstructured":"Savva C, Adhikaree J, Madhusudan S, Chokkalingam K (2019) Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature. J Diabetes Metab Disord 18:267\u2013272. https:\/\/doi.org\/10.1007\/s40200-019-00398-y","journal-title":"J Diabetes Metab Disord"},{"key":"1231_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1210\/jc.2012-3473","volume":"98","author":"DE Leaf","year":"2013","unstructured":"Leaf DE, Pereira RC, Bazari H, J\u00fcppner H (2013) Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab 98:887\u2013891. https:\/\/doi.org\/10.1210\/jc.2012-3473","journal-title":"J Clin Endocrinol Metab"},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/RLU.0b013e3182a20ded","volume":"38","author":"X Jin","year":"2013","unstructured":"Jin X, Jing H, Li F, Zhuang H (2013) Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy. Clin Nucl Med 38:922\u2013924. https:\/\/doi.org\/10.1097\/RLU.0b013e3182a20ded","journal-title":"Clin Nucl Med"},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1231_CR13","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/ndt\/gfab331","volume":"37","author":"L Derain Dubourg","year":"2021","unstructured":"Derain Dubourg L, Aurelle M, Chardon L et al (2021) Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine. Nephrol Dial Transplant 37:2150\u20132156. https:\/\/doi.org\/10.1093\/ndt\/gfab331","journal-title":"Nephrol Dial Transplant"},{"key":"1231_CR14","unstructured":"Amin MB, American Joint Committee on Cancer, American Cancer Society (2017) AJCC cancer staging manual, Eight edition\/editor-in-chief, Mahul B. Amin, MD, FCAP ;eds, Stephen B. Edge, MD, FACS [and 16 others]; Donna M. Gress, RHIT, CTR-Technical editor; Laura R. Meyer, CAPM-Managing editor. American Joint Committee on Cancer, Springer, Chicago"},{"key":"1231_CR15","doi-asserted-by":"publisher","first-page":"14896","DOI":"10.3390\/ijms232314896","volume":"23","author":"L Cianferotti","year":"2022","unstructured":"Cianferotti L (2022) Osteomalacia is not a single disease. Int J Mol Sci 23:14896. https:\/\/doi.org\/10.3390\/ijms232314896","journal-title":"Int J Mol Sci"},{"key":"1231_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0025-6196(11)61528-0","volume":"80","author":"PJ Tebben","year":"2005","unstructured":"Tebben PJ, Kalli KR, Cliby WA et al (2005) Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc 80:745\u2013751. https:\/\/doi.org\/10.1016\/S0025-6196(11)61528-0","journal-title":"Mayo Clin Proc"},{"key":"1231_CR17","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1210\/jc.2014-2120","volume":"99","author":"H-A Lin","year":"2014","unstructured":"Lin H-A, Shih S-R, Tseng Y-T et al (2014) Ovarian cancer-related hypophosphatemic osteomalacia\u2014a case report. J Clin Endocrinol Metab 99:4403\u20134407. https:\/\/doi.org\/10.1210\/jc.2014-2120","journal-title":"J Clin Endocrinol Metab"},{"key":"1231_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1373\/clinchem.2013.211490","volume":"60","author":"QH Meng","year":"2014","unstructured":"Meng QH, Xu E, Hildebrandt MAT et al (2014) Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin Chem 60:222\u2013232. https:\/\/doi.org\/10.1373\/clinchem.2013.211490","journal-title":"Clin Chem"},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13224-021-01572-0","volume":"72","author":"J Paul","year":"2022","unstructured":"Paul J, Jose A, Kingsbury B et al (2022) Ovarian teratoma causing oncogenic osteomalacia: an instance of serendipity. J Obstet Gynaecol India 72:353\u2013355. https:\/\/doi.org\/10.1007\/s13224-021-01572-0","journal-title":"J Obstet Gynaecol India"},{"key":"1231_CR20","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127\u20132133. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"1231_CR21","volume-title":"WHO classification of tumours of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, World Health Organization, International Agency for Research on Cancer (2013) WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon","edition":"4"},{"key":"1231_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia W-B et al (2023) Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med 293:309\u2013328. https:\/\/doi.org\/10.1111\/joim.13593","journal-title":"J Intern Med"},{"key":"1231_CR23","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH et al (2011) Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res Off J Am Soc Bone Miner Res 26:1295\u20131302. https:\/\/doi.org\/10.1002\/jbmr.316","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"1231_CR24","doi-asserted-by":"publisher","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","volume":"107","author":"D Rendina","year":"2022","unstructured":"Rendina D, Abate V, Cacace G et al (2022) Tumor-induced osteomalacia: a systematic review and individual patient\u2019s data analysis. J Clin Endocrinol Metab 107:e3428\u2013e3436. https:\/\/doi.org\/10.1210\/clinem\/dgac253","journal-title":"J Clin Endocrinol Metab"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"e10190","DOI":"10.1002\/jbm4.10190","volume":"3","author":"EA Imel","year":"2019","unstructured":"Imel EA, Biggin A, Schindeler A, Munns CF (2019) FGF23, hypophosphatemia, and emerging treatments. JBMR Plus 3:e10190. https:\/\/doi.org\/10.1002\/jbm4.10190","journal-title":"JBMR Plus"},{"key":"1231_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","volume":"111","author":"A Bosman","year":"2022","unstructured":"Bosman A, Palermo A, Vanderhulst J et al (2022) Tumor-induced osteomalacia: a systematic clinical review of 895 cases. Calcif Tissue Int 111:367\u2013379. https:\/\/doi.org\/10.1007\/s00223-022-01005-8","journal-title":"Calcif Tissue Int"},{"key":"1231_CR27","doi-asserted-by":"publisher","first-page":"S314","DOI":"10.1016\/S1166-7087(20)30755-7","volume":"30","author":"T Murez","year":"2020","unstructured":"Murez T, Savoie P-H, Fl\u00e9chon A et al (2020) Recommandations fran\u00e7aises du Comit\u00e9 de canc\u00e9rologie de l\u2019AFU\u2014actualisation 2020\u20132022: sarcomes r\u00e9trop\u00e9riton\u00e9aux. Prog En Urol 30:S314\u2013S330. https:\/\/doi.org\/10.1016\/S1166-7087(20)30755-7","journal-title":"Prog En Urol"},{"key":"1231_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00223-009-9275-1","volume":"85","author":"D Rendina","year":"2009","unstructured":"Rendina D, De Filippo G, Tauchmanov\u00e0 L et al (2009) Bone turnover and the osteoprotegerin\u2013RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. Calcif Tissue Int 85:293\u2013300. https:\/\/doi.org\/10.1007\/s00223-009-9275-1","journal-title":"Calcif Tissue Int"},{"key":"1231_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00223-018-0429-x","volume":"103","author":"L Colangelo","year":"2018","unstructured":"Colangelo L, Cipriani C, Pepe J et al (2018) A challenging case of tumor-induced osteomalacia: pathophysiological and clinical implications. Calcif Tissue Int 103:465\u2013468. https:\/\/doi.org\/10.1007\/s00223-018-0429-x","journal-title":"Calcif Tissue Int"},{"key":"1231_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/ijms20030695","volume":"20","author":"A Mansinho","year":"2019","unstructured":"Mansinho A, Ferreira AR, Casimiro S et al (2019) Levels of circulating fibroblast growth factor 23 (FGF23) and prognosis in cancer patients with bone metastases. Int J Mol Sci 20:695. https:\/\/doi.org\/10.3390\/ijms20030695","journal-title":"Int J Mol Sci"},{"key":"1231_CR31","doi-asserted-by":"publisher","first-page":"19647","DOI":"10.18632\/oncotarget.3794","volume":"6","author":"A Suvannasankha","year":"2015","unstructured":"Suvannasankha A, Tompkins DR, Edwards DF et al (2015) FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget 6:19647\u201319660. https:\/\/doi.org\/10.18632\/oncotarget.3794","journal-title":"Oncotarget"},{"key":"1231_CR32","doi-asserted-by":"publisher","first-page":"15885","DOI":"10.3390\/ijms140815885","volume":"14","author":"NG Gavalas","year":"2013","unstructured":"Gavalas NG, Liontos M, Trachana S-P et al (2013) Angiogenesis-related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci 14:15885\u201315909. https:\/\/doi.org\/10.3390\/ijms140815885","journal-title":"Int J Mol Sci"},{"key":"1231_CR33","first-page":"3495","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Tian B, Liu M et al (2022) Adult-type granulosa cell tumor of the ovary. Am J Cancer Res 12:3495\u20133511","journal-title":"Am J Cancer Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01231-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:03:35Z","timestamp":1720861415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01231-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01231-2","relation":{},"ISSN":["1432-0827"],"issn-type":[{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marcodomenico Mazza, Gaetano Paride Arcidiacono, Ilda Hoxhaj, Virginia Padoan, Giulia Tasca, Marta Burei, Stefania Sella, Paolo, Simioni, Sandro Giannini, Simone Mocellin declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient has provided informed consent for the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Rights"}}]}}